Log on / register
Feedback | Support | My details
Activity of opioid ligands in cells expressing cloned mu opioid receptors.
Gharagozlou P, Demirci H, David Clark J, Lameh J
BMC Pharmacol 2003 Jan 4, 3:1
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Opioid antagonists differ according to negative intrinsic efficacy in a mouse model of acute dependence.
Walker EA, Sterious SN
Br J Pharmacol 2005 Aug, 145:975-83
[PubMed Central] [PubMed] [Related articles]

2.
Differential activation of G-proteins by mu-opioid receptor agonists.
Saidak Z, Blake-Palmer K, Hay DL, Northup JK, Glass M
Br J Pharmacol 2006 Mar, 147:671-80
[PubMed Central] [PubMed] [Related articles]

3.
CC12, a high-affinity ligand for [3H]cimetidine binding, is an improgan antagonist.
Hough LB, Nalwalk JW, Phillips JG, Kern B, Shan Z, Wentland MP, de Esch IJ, Janssen E, Barr T, Stadel R
Neuropharmacology 2007 Apr, 52:1244-55
[PubMed Central] [PubMed] [Related articles]

4.
Effects of nalbuphine on anterior pituitary and adrenal hormones and subjective responses in male cocaine abusers.
Goletiani NV, Mendelson JH, Sholar MB, Siegel AJ, Skupny A, Mello NK
Pharmacol Biochem Behav 2007 Apr, 86:667-77
[PubMed Central] [PubMed] [Related articles]


This article is also cited by 2 articles in BioMed Central

printer friendly 
to  [Help]

© 1999-2008 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.